ArticleNature communications2025
Chemoselective synthesis of fluoroacetonitrile-containing terminal groups for stable non-fullerene acceptors.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The intrinsic instability of non-fullerene acceptors (NFAs), primarily caused by vulnerable exocyclic vinyl linkages, significantly undermines the operational lifetime of organic solar cells (OSCs). In this work, we address this challenge by designing robust molecular framework that incorporates fluoroacetonitrile-containing terminal groups. This terminal group enables the formation of a F···H interaction between itself and the exocyclic vinyl linkage. Leveraging this F···H interaction, we can readily synthesize the preferable E isomer with exclusive regioselectivity. Moreover, the F···H interaction locks the molecular conformation, resulting in a more planar structure, and thereby enhancing molecular packing and film morphology. Critically, this interaction stabilizes the exocyclic vinyl linkage, significantly boosting the chemical and photo-stability and suppressing terminal-group redistribution of the NFAs. When paired with the low-cost polymer donor P3HT, the symmetric acceptor E-2IFC-F achieves a power conversion efficiency (PCE) of 11.77%, setting a high benchmark for P3HT-based OSCs. Furthermore, the asymmetric acceptor E-IFC-IC-Cl, with its optimized energy levels, delivers a PCE of 19.31% when combined with the donor PM6. All of the devices based on these NFAs exhibit better stability. This work presents a paradigm for developing high-efficiency, stable, and low-cost OSCs, highlighting the potential of fluoroacetonitrile-containing terminal groups in enhancing NFA performance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.